HFE cross-talks with the MHC class I antigen presentation pathway

Blood

Volumn 106, Issue 3, 2005, Pages 971-977

  De Almeida, Sérgio F ^b   Carvalho, Isabel F ^b   Cardoso, Carla S ^b   Cordeiro, João V ^b   Azevedo, Jorge E ^b   Neefjes, Jacques ^b   De Sousa, Maria ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; HFE PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MUTANT PROTEIN; PEPTIDE;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL MUTANT; CELL SURFACE; CONTROLLED STUDY; DISSOCIATION; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; FLOW CYTOMETRY; GENE MUTATION; GENOTYPE; HEAVY CHAIN; HEMOCHROMATOSIS; HUMAN; HUMAN CELL; IRON METABOLISM; MOLECULAR INTERACTION; MUTATIONAL ANALYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SEQUENCE HOMOLOGY; THERMOSTABILITY;

EID: 23044509138     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-12-4640     Document Type: Article

References (44)

1. Rock KL, Goldberg AL. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu Rev Immunol. 1999;17: 739-779.
2. Belts EA, Vos JC, Gramme M, Neefjes J. The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature. 2000;404: 774-778.
3. Schubert U, Anton LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature. 2000;404;770-774.
4. Reits E, Neijssen J, Herberts C, et al. A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. Immunity. 2004;20:495-506.
5. Neefjes JJ, Momburg F, Hammerling GJ. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science. 1993; 261:769-77.1.
6. Shepherd JC, Schumacher TN, Ashton-Rickardt PG, et al. TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell. 1993;74:577-584.
7. Androlewicz MJ, Anderson KS, Cresswell P. Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc Natl Acad Sci U S A. 1993;90:9130-9134.
8. Androlewicz MJ, Cresswell P. Human transporters associated with antigen processing possess a promiscuous peptide-binding site. Immunity. 1994;1:7-14.
9. Serwold T, Gonzalez F, Kim J, Jacob R, Shastri N. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature. 2002;419:480-483.
10. Saric T, Chang SC, Hattori A, et al. An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat Immunol. 2002;3:1169-1176.
11. Cresswell P, Bangia N, Dick T, Diedrich G. The nature of the MHC class I peptide loading complex. Immunol Rev. 1999;172:21-28.
12. Cresswell P. Intracellular surveillance: controlling the assembly of MHC class I-peptide complexes. Traffic. 2000;1:301-305.
13. Marguet D, Spiliotis ET, Pentcheva T, Lebowitz M, Schneck J, Edidin M. Lateral diffusion of GFP-tagged H2Ld molecules and of GFP-TAP1 reports on the assembly and retention of these molecules in the endoplasmic reticulum. Immunity. 1999;11:231-240.
14. Spiliotis ET, Manley H, Osorio M, Zuniga MC, Edidin M. Selective export of MHC class I molecules from the ER after their dissociation from TAP. Immunity. 2000;13:841-851.
15. Paulsson KM, Wang P. Quality control of MHC class I maturation. FASEB J. 2004;18:31-38.
16. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet. 1997;34:275-278.
17. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996; 13:399-408.
18. Lebron JA, Bennett MJ, Vaughn DE, et al. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell. 1998;93:111-123.
19. Feder JN, Tsuchihashi Z, Irrinki A, et al. The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J Biol Chem. 1997;272:14025-14028.
20. Waheed A, Parkkila S, Zhou XY, et al. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci USA. 1997;94:12384-12389.
21. Roy CN, Carlson EJ, Anderson EL, et al. Interactions of the ectodomain of HFE with the transferrin receptor are critical for iron homeostasis in cells. FEBS Lett. 2000;484:271-274.
22. Feder JN, Penny DM, Irrinki A, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA. 1998;95: 1472-1477.
23. Parkkila S, Waheed A, Britton RS, et al. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci U S A. 1997;94:13198-13202.
24. Leibman A, Aisen P. Transferrin receptor of the rabbit reticulocyte. Biochemistry. 1977;16:1268-1272.
25. Reimao R, Porto G, de Sousa M. Stability of CD4/ CD8 ratios in man: new correlation between CD4/ CD8 profiles and iron overload in idiopathic haemochromatosis patients. C R Acad Sci III. 1991; 313:481-487.
26. Porto G, Vicente C, Teixeira MA, et al. Relative impact of HLA phenotype and CD4-CD8 ratios on the clinical expression of hemochromatosis. Hepatology. 1997;25:397-402.
27. Arosa FA, da Silva AJ, Godinho IM, et al. Decreased CD8-p56lck activity in peripheral blood T-lymphocytes from patients with hereditary haemochromatosis. Scand J Immunol. 1994;39:426-432.
28. Cardoso C, Porto G, Lacerda R, et al. T-cell receptor repertoire in hereditary hemochromatosis: a study of 32 hemochromatosis patients and 274 healthy subjects. Hum Immunol. 2001;62:488-499.
29. - T cells. Clin Exp Immunol. 1997;107:548-554.
30. Ben-Arieh SV, Zimerman B, Smorodinsky NI, et al. Human cytomegalovirus protein US2 interferes with the expression of human HFE, a non-classical class I major histocompatibility complex molecule that regulates iron homeostasis. J Virol. 2001;75:10557-10562.
31. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
32. Neefjes JJ, Hammerling GJ, Momburg F. Folding and assembly of major histocompatibility complex class I heterodimers in the endoplasmic reticulum of intact cells precedes the binding of peptide. J Exp Med. 1993;178:1971-1980.
33. Schumacher TN, Heemels MT, Neefjes JJ, Kast WM, Melief CJ, Ploegh HL. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell. 1990;62:563-567.
34. Townsend A, Elliott T, Cerundolo V, Foster L, Barber B, Tse A. Assembly of MHC class I molecules analyzed in vitro. Cell. 1990;62:285-295.
35. Baas EJ, van Santen HM, Kleijmeer MJ, Geuze HJ, Peters PJ, Ploegh HL. Peptide-induced stabilization and intracellular localization of empty HLA class I complexes. J Exp Med. 1992;176:147-156.
36. Ljunggren HG, Stam NJ, Ohlen C, et al. Empty MHC class I molecules come out in the cold. Nature. 1990;346:476-480.
37. Yewdell JW, Bennink JR. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. Science. 1989;244:1072-1075.
38. Rein RS, Seemann GH, Neefjes JJ, Hochstenbach FM, Stam N J, Ploegh HL. Association with beta 2-microglobulin controls the expression of transfected human class I genes. J Immunol. 1987;138:1178-1183.
39. Lewis JW, Elliott T. Evidence for successive peptide binding and quality control stages during MHC class I assembly. Curr Biol. 1998;8:717-720.
40. Brocke P, Garbi N, Momburg F, Hammerling GJ. HLA-DM, HLA-DO and tapasin: functional similarities and differences. Curr Opin Immunol. 2002;14:22-29.
41. Vahdati-Ben Arieh S, Laham N, et al. A single viral protein HCMV US2 affects antigen presentation and intracellular iron homeostasis by degradation of classical HLA class I and HFE molecules. Blood. 2003;101:2858-2864.
42. Cardoso EM, Duarte MA, Ribeiro E, et al. A study of some hepatic immunological markers, iron load and virus genotype in chronic hepatitis C. J Hepatol. 2004;41:319-326.
43. Biassoni R, Cantoni C, Pende D, et al. Human natural killer cell receptors and co-receptors. Immunol Rev. 2001;181:203-214.
44. Oberg L, Johansson S, Michaelsson J, et al. Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo-role of KARAP/DAP12-dependent and -independent pathways. Eur J Immunol. 2004;34: 1646-1653.